Nashai Biotech Patents Skin Care Composition
Published February 16, 2007
Patent No. US 7,157,493 B2: A method of reducing low density lipoprotein while not significantly reducing high density lipoprotein using a theaflavin, theaflavin-3-gallate, theaflavin-3’-gallate and theaflavin 3,3’-digallate has been patented by Nashai Biotech, LLC, Nashville, TN.
blog comments powered by Disqus